Doxepin

CHEMBL1628227 Phase 4 Zugelassen Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
279.4 g/mol
LogP
4.3
Phase
4

A tricyclic antidepressant also used in low doses to treat insomnia. It works by affecting multiple neurotransmitter systems including serotonin, norepinephrine, and histamine.

Molekularmasse

279,4000 g/mol

LogP

4,30

TPSA

12,50 Ų

Lipinski-Regel der Fünf

Bestanden

Therapeutische Bereiche

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D-Struktur

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CN(C)CCC=C1c2ccccc2COc2ccccc21

InChI

InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3

Molecular Formula

C19H21NO

HBD / HBA

- / 2

Rotierbare Bindungen

3

Schwere Atome

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Häufig gestellte Fragen

A tricyclic antidepressant also used in low doses to treat insomnia. It works by affecting multiple neurotransmitter systems including serotonin, norepinephrine, and histamine.

Yes, Doxepin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1628227. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3158. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medizinischer Haftungsausschluss

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.